But the animal vaccine production works differently. Let me quick stay on the human vaccine because I think this is important. We had a pretty robust vaccine production capability. But then it was reduced dramatically. A lot of those lawsuits, that type of thing, people, you know, it just was not an attractive business to be in. So people, drug manufacturers exited the vaccine business. (19:30–19:36)
CLAIM
Asserts that the U.S. vaccine production capability was once robust but has since been significantly reduced.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
